mRNA |
PD-0332991 |
GDSC1000 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
BRD-K55473186 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.4 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.029 |
0.4 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.4 |
mRNA |
PRIMA-1-Met |
CTRPv2 |
pan-cancer |
AAC |
-0.043 |
0.4 |
mRNA |
LAQ824 |
GDSC1000 |
pan-cancer |
AAC |
0.026 |
0.4 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.4 |
mRNA |
LFM-A13 |
GDSC1000 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
-0.044 |
0.5 |